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ABSTRACT 1 
TOCOTRIENOL-TOCOPHEROL MIXED FRACTION 
SUPPLEMENTATION PREVENTS LESION PROGRESSION IN 
EARLY AND ESTABLISHED ATHEROSCLEROSIS 
Aishah NM, Omar E, Azlina AR, Nawawi H 
Faculty of Medicine, Universiti Teknologi MARA, Shah Alam, Selangor, 
Malaysia. 
Background: Inflammation plays a key role in plaque stability and the 
pathogenesis of atherosclerosis. Palm-derived tocotrienol-tocopherol mixed-
fraction (TTMF) is a potent antioxidant with anti-inflammatory effects. The 
effect of TTMF on the development of early and established atherosclerosis 
remains unclear. 
Objective: To determine the anti-inflammatory effects of TTMF in rabbits with 
early and established atherosclerotic lesions. 
Materials and methods: 60 New Zealand white rabbits were randomized into 
three major groups which further divided into two groups each with 
supplementation: (i) TTMF (15mg/kg) or (ii) placebo. Group A were given 
intervention of TTMF for 2 month followed by high cholesterol diet for either 2 
weeks or 2 month with TTMF while group B were induced with high cholesterol 
diet for either 2 weeks or 2 month before stopped the high cholesterol diet and 
intervened with TTMF. Group C were given both TTMF and high cholesterol 
diet concurrently. Blood samples at the intervention interval were analyzed for 
serum lipid and soluble CRP. At the end of the study, the aortas were evaluated 
for atherosclerotic lesion using Sudan IV stain and immunohistochemistry 
staining. Quantitative analysis of the lesion staining was performed using image 
analysis software. 
Results: There were significantly reduced atherosclerotic lesions in early (Mean 
± SEM; TTMF vs. placebo:7.92 ±2.9 vs. 16.6 ± 1.6 %; p<0.05) and established 
atherosclerosis (Mean ± SEM; TTMF vs. placebo : 8.45 ± 2.03 vs. 29.47 ± 
4.83%; p<0.05) in Group A. Expressions of E-selectin were also significantly 
reduced in established atherosclerosis in Group A (Mean ± SEM; TTMF vs. 
placebo: 6.70 ± 1.43 vs. 21.18 ± 2.81 %;p<0.05) and in early atherosclerosis 
(Mean ± SEM; TTMF vs. placebo : 0.87 ± 0.23 vs. 5.82 ± 2.05 % ; p<0.05) of 
Bl group. Group C showed no differences in both early and established 
atherosclerosis with TTMF. However, TTMF gives neutral effects on blood 
biomarkers of all three groups. 
Conclusion: TTMF effectively prevents atherosclerotic lesions and 
inflammatory marker in early and established atherosclerosis. Further studies 
should emphasis on the tocotrienol isomers for the therapeutic potential of 
atherosclerosis. 
